Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers Kim J, Bamlet WR, Oberg AL, Chaffee KG, Donahue G, Cao XJ, Chari S, Garcia BA, Petersen GM, Zaret […]
Managing cell and human identity. Moreno J, Gearhart J, Zoloth L, Pyeritz R, Zaret KS. Science. 2017 Apr 14;356(6334):139-140. doi: 10.1126/science.aan2763.
Cell fate conversion: a chromatin remodeling checkpoint revealed. Zaret KS. Cell Res. 2017 May;27(5):598-599. doi: 10.1038/cr.2017.44. Epub 2017 Mar 31.
Erratum for Zaret, At the Revolution with Fred Sherman Zaret KS. Mol Cell Biol. 2017 Feb 15;37(5). pii: e00671-16. doi: 10.1128/MCB.00671-16. Print 2017 Mar 1.
The Chromatin Modifier MSK1/2 Suppresses Endocrine Cell Fates during Mouse Pancreatic Development. Bhat N, Park J, Zoghbi HY, Arthur JS, Zaret KS. PLoS One. 2019 Dec 14;11(12):e0166703. doi: 10.1371/journal.pone.0166703. eCollection […]
Cell fate control by pioneer transcription factors. Iwafuchi-Doi M, Zaret KS. Development. 2016 Jun 1;143(11):1833-7. doi: 10.1242/dev.133900.
The Pioneer Transcription Factor FoxA Maintains an Accessible Nucleosome Configuration at Enhancers for Tissue-Specific Gene Activation. Iwafuchi-Doi M, Donahue G, Kakumanu A, Watts JA, Mahony S, Pugh BF, Lee D, […]
From Endoderm to Liver Bud: Paradigms of Cell Type Specification and Tissue Morphogenesis. Ken Zaret. Curr Top Dev Biol. 2016;117:647-69. doi: 10.1016/bs.ctdb.2015.12.015. Epub 2016 Jan 21.
H3K9me3-Dependent Heterochromatin: Barrier to Cell Fate Changes. Becker JS, Nicetto D, Zaret KS. Trends Genet. 2016 Jan;32(1):29-41. doi: 10.1016/j.tig.2015.11.001. Epub 2015 Dec 8. Review.